Clinical Trials Browser

Phase 2 × NETWORK × iberdomide × Clear all

NCT04564703 2025-02-25

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

Phase 2 Active not recruiting

Multiple Myeloma